The effect of intra-nasal tetra sodium pyrophosphate on decreasing elevated nasal calcium and improving olfactory function post COVID-19: a randomized controlled trial
- PMID: 35927706
- PMCID: PMC9354346
- DOI: 10.1186/s13223-022-00711-0
The effect of intra-nasal tetra sodium pyrophosphate on decreasing elevated nasal calcium and improving olfactory function post COVID-19: a randomized controlled trial
Abstract
Background: Olfactory dysfunction is recognized as a symptom of COVID-19. Reports revealed the nasal calcium increase has adverse effects on olfactory function. Tetra sodium pyrophosphate, a chelating agent, can bind calcium and help improve olfaction.
Methods: Sixty-four patients with olfactory dysfunction persisting for more than 90 days after COVID-19 were recruited. Participants were divided into 2 groups that received either 0.9% sodium chloride or 1% tetra sodium pyrophosphate for topical application. Olfactory function was tested with the Sniffin' Sticks test before treatment and 1 month later. In addition, nasal calcium was determined with an ion-selective electrode.
Results: After topical application of tetra sodium pyrophosphate compared to sodium chloride, improvement from anosmia to hyposmia with decrease in calcium level was demonstrated. As for the results of tetra-sodium pyrophosphate, 81% showed improved olfactory function and 19% did not exhibit olfaction improvement.
Conclusions: Intranasal application of tetra sodium pyrophosphate may be associated with improvement in olfactory function after COVID -19 infection. Trial registration Ethical Committee of Damietta Faculty of Medicine approved this study on January 2021 (approval number, IRB 00012367-21-03-010).
Keywords: COVID-19; Calcium; Chelating agent; Olfactory disorder; Tetra sodium pyrophosphate.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
The Efficacy of Sodium Phytate as a Natural Chelating Agent in Reducing Elevated Calcium Levels in Nasal Mucus Among Individuals Experiencing Olfactory Dysfunction Following COVID-19: A Prospective Randomized Double-Controlled Clinical Trial.Am J Rhinol Allergy. 2024 Mar;38(2):116-122. doi: 10.1177/19458924231220545. Epub 2023 Dec 17. Am J Rhinol Allergy. 2024. PMID: 38105576 Clinical Trial.
-
Effect of Sodium Gluconate on Decreasing Elevated Nasal Calcium and Improving Olfactory Function Post COVID-19 Infection.Am J Rhinol Allergy. 2022 Nov;36(6):841-848. doi: 10.1177/19458924221120116. Epub 2022 Aug 9. Am J Rhinol Allergy. 2022. PMID: 35942688 Free PMC article. Clinical Trial.
-
Intra Nasal Use of Ethylene Diamine Tetra Acetic Acid for Improving Olfactory Dysfunction Post COVID-19.Am J Rhinol Allergy. 2023 Nov;37(6):630-637. doi: 10.1177/19458924231184055. Epub 2023 Jun 25. Am J Rhinol Allergy. 2023. PMID: 37786364 Free PMC article. Clinical Trial.
-
Olfactory changes after endoscopic sinus surgery for chronic rhinosinusitis: A meta-analysis.Clin Otolaryngol. 2021 Jan;46(1):41-51. doi: 10.1111/coa.13639. Epub 2020 Sep 23. Clin Otolaryngol. 2021. PMID: 32865350
-
Olfactory Outcomes after Endoscopic Sinus Surgery for Chronic Rhinosinusitis: A Meta-analysis.Otolaryngol Head Neck Surg. 2016 Dec;155(6):936-948. doi: 10.1177/0194599816664879. Epub 2016 Aug 30. Otolaryngol Head Neck Surg. 2016. PMID: 27576679 Review.
Cited by
-
Olfactory Function and Olfactory Disorders.Laryngorhinootologie. 2023 May;102(S 01):S67-S92. doi: 10.1055/a-1957-3267. Epub 2023 May 2. Laryngorhinootologie. 2023. PMID: 37130532 Free PMC article.
-
Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms.Front Neurosci. 2023 Aug 4;17:1165329. doi: 10.3389/fnins.2023.1165329. eCollection 2023. Front Neurosci. 2023. PMID: 37599993 Free PMC article. Review.
-
Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review.Int Arch Otorhinolaryngol. 2024 May 25;28(4):e728-e743. doi: 10.1055/s-0044-1786046. eCollection 2024 Oct. Int Arch Otorhinolaryngol. 2024. PMID: 39464360 Free PMC article. Review.
-
Delivery of Topical Drugs to the Olfactory Cleft.J Clin Med. 2023 Nov 29;12(23):7387. doi: 10.3390/jcm12237387. J Clin Med. 2023. PMID: 38068438 Free PMC article. Review.
-
Clinical and Imaging Evaluation of COVID-19-Related Olfactory Dysfunction.Am J Rhinol Allergy. 2023 Jul;37(4):456-463. doi: 10.1177/19458924231163969. Epub 2023 Mar 21. Am J Rhinol Allergy. 2023. PMID: 36945746 Free PMC article.
References
-
- Sell CS. Chemistry and the Sense of Smell. Hoboken: Wiley; 2014.
-
- González LM, Graham RK, Frigon A, Cohen A. Abnormalities in the olfactory system and its modulation as a therapeutic approach in mild cognitive impairment. 2021.
LinkOut - more resources
Full Text Sources
Research Materials